List of Excipients in API hydrochlorothiazide and triamterene
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydrochlorothiazide and triamterene
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| GlaxoSmithKline LLC | DYAZIDE | hydrochlorothiazide and triamterene | 0007-3650 | BENZYL ALCOHOL | |
| GlaxoSmithKline LLC | DYAZIDE | hydrochlorothiazide and triamterene | 0007-3650 | CELLULOSE, MICROCRYSTALLINE | |
| GlaxoSmithKline LLC | DYAZIDE | hydrochlorothiazide and triamterene | 0007-3650 | CETYLPYRIDINIUM CHLORIDE | |
| GlaxoSmithKline LLC | DYAZIDE | hydrochlorothiazide and triamterene | 0007-3650 | D&C RED NO. 33 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing hydrochlorothiazide and triamterene
Detailed excipient profiles for hydrochlorothiazide and triamterene
Excipient focus: BENZYL ALCOHOL
hydrochlorothiazide and triamterene drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
hydrochlorothiazide and triamterene drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CETYLPYRIDINIUM CHLORIDE
hydrochlorothiazide and triamterene drug variants containing CETYLPYRIDINIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing CETYLPYRIDINIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
hydrochlorothiazide and triamterene drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
hydrochlorothiazide and triamterene drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
hydrochlorothiazide and triamterene drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
hydrochlorothiazide and triamterene drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
hydrochlorothiazide and triamterene drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
hydrochlorothiazide and triamterene drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
hydrochlorothiazide and triamterene drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
hydrochlorothiazide and triamterene drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
hydrochlorothiazide and triamterene drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
hydrochlorothiazide and triamterene drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCINE
hydrochlorothiazide and triamterene drug variants containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
hydrochlorothiazide and triamterene drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
hydrochlorothiazide and triamterene drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
hydrochlorothiazide and triamterene drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
hydrochlorothiazide and triamterene drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
hydrochlorothiazide and triamterene drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
hydrochlorothiazide and triamterene drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
hydrochlorothiazide and triamterene drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
hydrochlorothiazide and triamterene drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
hydrochlorothiazide and triamterene drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
hydrochlorothiazide and triamterene drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
hydrochlorothiazide and triamterene drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide and triamterene drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
